ClinicalTrials.govpublic full text
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.
non-small cell lung cancer, advanced, non-squamous, first line therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876986
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.